NYSE$COR

Cencora Inc · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Reported a 13.5 percent increase in revenue year-over-year and an increase in adjusted diluted EPS of 18.3 percent.

AmerisourceBergen reported a strong first quarter with revenue increasing by 13.5% year-over-year to $59.6 billion. Adjusted diluted EPS increased by 18.3% to $2.58. The company has raised its adjusted diluted EPS guidance for fiscal year 2022 to a range of $10.60 to $10.90.

  • Revenue increased 13.5 percent year-over-year to $59.6 billion.
  • GAAP diluted EPS was $2.13 for the December quarter of fiscal 2022, compared to $1.81 in the prior year quarter.
  • Adjusted diluted EPS increased 18.3 percent to $2.58 in the fiscal first quarter.
  • Adjusted diluted EPS guidance has been raised from the previous range of $10.50 to $10.80 to a range of $10.60 to $10.90.

Headline financials

Total Revenue

$59.6B

Previous: $52.5B+13.5%
EPS (adj)

$2.58

Previous: $2.18+18.3%
Effective Tax Rate

24.6%

Previous: 28.3%-13.1%
Adj. Effective Tax Rate

21.3%

Previous: 22.0%-3.2%
Capital Expenditures

-$79.7M

Previous: -$65.4M-21.8%
Free Cash Flow

$369M

Previous: $309M+19.4%
Net Income

$449M

Previous: $375M+19.8%
Operating Income

$644M

Previous: $547M+17.8%
Gross Profit

$2.06B

Previous: $1.45B+41.9%
Cash & Equivalents

$3.17B

Previous: $4.89B-35.2%
Total Assets

$57.6B

Previous: $45.8B+25.6%
Stock-Based Comp

$42.9M

Previous: $48.3M-11.2%

Revenue & EPS history

Cencora · Revenue · Quarterly

$59.6B

Q1 2022+13.5%vs Q1 2021
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Forward guidance

AmerisourceBergen is updating its fiscal year 2022 financial guidance to reflect the updated full year expectations from COVID therapy distribution and higher interest expense. Adjusted Diluted Earnings Per Share to be in the range of $10.60 to $10.90, raised from the previous range of $10.50 to $10.80.

Tailwinds

  • Adjusted operating income growth to be in the high-teens percent range, up from growth in the mid- to high-teens percent range
  • U.S. Healthcare Solutions operating income to be in the range of $2.375 to $2.45 billion, representing growth of 5% to 9%, up from a range of $2.325 to $2.4 billion

Headwinds

  • Interest expense to be in the range of $210 to $215 million, up from growth in the mid-teens percent range.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

-0.1%

Avg return

Earnings day

+0.3%

Avg return

5 days after

+1.4%

Avg return

30 days after

48%

35 / 73 earnings

Positive

+7.8%

Q2 2019

Best reaction

-18.4%

Q2 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026-18.4%-16.6%-10.1%
Q1 2026-5.9%+0.4%-0.9%
Q4 2025+2.9%+5.8%-1.4%
Q3 2025-2.9%-0.6%+0.1%
Q2 2025+4.6%-4.3%-0.6%
Q1 2025+0.7%-2.1%+1.2%
Q4 2024+5.9%+6.5%+4.0%
Q3 2024+5.8%+4.4%+3.7%
Q2 2024-6.0%-6.3%-5.2%
Q1 2024+7.4%+6.2%+7.5%
Q4 2023+4.2%+4.7%+9.0%
Q3 2023+1.2%-1.3%-7.5%
Q2 2023+0.1%+0.7%+3.5%
Q1 2023-6.2%-8.6%-7.6%
Q4 2022+4.4%+3.1%+12.4%
Q3 2022-2.5%-1.5%+3.4%
Q2 2022+2.9%+4.4%-2.5%
Q1 2022+0.2%+1.3%+7.0%
Q4 2021-0.6%-2.8%-9.0%
Q3 2021-1.5%-2.8%+1.2%
Q2 2021-6.5%-2.1%-7.1%
Q1 2021+3.9%+1.8%-0.7%
Q4 2020-1.0%+4.8%-1.9%
Q3 2020-3.0%-1.6%-7.7%
Q2 2020+3.0%+3.6%+15.8%
Q1 2020-4.8%-2.0%-6.2%
Q4 2019+1.6%+1.0%+4.2%
Q3 2019+3.8%-3.5%-5.6%
Q2 2019+7.8%+5.5%+6.1%
Q1 2019+6.7%+9.2%+5.7%
Q4 2018-2.3%+0.3%-2.9%
Q3 2018+1.9%+5.0%+13.2%
Q2 2018-4.3%-5.1%-6.6%
Q1 2018+2.5%-2.9%+4.7%
Q4 2017-2.4%-2.2%+10.9%
Q3 2017-11.4%-12.0%-12.1%
Q2 2017+3.9%+5.9%+13.2%
Q1 2017+6.0%+6.8%+9.9%
Q4 2016+3.6%+3.1%+12.9%
Q3 2016+5.1%+4.5%+1.9%
Q2 2016-9.2%
Q1 2016-3.7%
Q4 2015-1.0%
Q3 2015-5.4%
Q2 2015+1.9%
Q1 2015+0.4%
Q4 2014+7.1%
Q3 2014+3.7%
Q2 2014-3.1%
Q1 2014-4.3%
Q4 2013+1.8%
Q3 2013-0.0%
Q2 2013-4.6%
Q1 2013-5.1%
Q4 2012-0.6%
Q3 2012+2.7%
Q2 2012-1.2%
Q1 2012+2.4%
Q4 2011-1.0%
Q3 2011-0.5%
Q2 2011+2.9%
Q1 2011+0.5%
Q4 2010-0.5%
Q3 2010-0.7%
Q2 2010+1.0%
Q1 2009-1.7%
Q1 2010+1.2%
Q4 2009-0.6%
Q2 2009-0.6%
Q4 2007-0.6%
Q3 2008-0.5%
Q3 2009-0.5%
Q4 2008-0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro